114142-19-7

Upstream product

• 288-32-4 1H-imidazole 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 147347-97-5 5-(t-butyldiphenylsilyloxy)-2,2-di(phenylthio)pentan-4-olide 
• 123827-81-6 (2R,4R,5R)-1-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-hexane-2,5-diol 
• 123827-81-6 (2R,4R,5S)-1-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-hexane-2,5-diol 
• 123827-81-6 (2R,4S,5R)-1-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-hexane-2,5-diol 
• 123827-81-6 (2R,4S,5S)-1-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-hexane-2,5-diol 
• 103233-24-5 (3S,5S)-5-(tert-Butyl-diphenyl-silanyloxymethyl)-3-methyl-dihydro-furan-2-one 
• 103233-24-5 (3R,5S)-5-(tert-Butyl-diphenyl-silanyloxymethyl)-3-methyl-dihydro-furan-2-one 

Relevant academic research and scientific papers

An effective cis-β-octahedral Mn(iii) SALPN catalyst for the Mukaiyama-Isayama hydration of α,β-unsaturated esters

Two cis-β-MnIIISALPN catalysts were synthesised and tested in the Mukaiyama-Isayama hydration of α,β-unsaturated esters. The MnIIIEtOSALPN(acac) complex 7 is the most active and catalyses hydration with little or no detectable undesired alkene reduction. This catalyst is superior for alkene hydration compared to the originally reported Mn(dpm)3 catalyst.

Pyrimidine intermediates

The present invention is directed to compounds of formula (I), STR1 wherein R1 is OH, NH2 ; R2 is a heteroaromatic or aromatic substituent; R3 is H, OH, F, OCH3 ; R4 is H, F, OH or an ether